Single dose oral acemetacin for acute postoperative pain in adults
- PMID: 19588437
- PMCID: PMC4170991
- DOI: 10.1002/14651858.CD007589.pub2
Single dose oral acemetacin for acute postoperative pain in adults
Abstract
Background: Acemetacin is a non-steroidal anti-inflammatory drug (NSAID) licensed for use in rheumatic disease and other musculoskeletal disorders in the UK, and widely available in other countries worldwide. This review sought to evaluate the efficacy and safety of oral acemetacin in acute postoperative pain, using clinical studies of patients with established pain, and with outcomes measured primarily over 6 hours using standard methods. This type of study has been used for many decades to establish that drugs have analgesic properties.
Objectives: To assess the efficacy of single dose oral acemetacin in acute postoperative pain, and any associated adverse events.
Search strategy: We searched CENTRAL (Issue 2, 2009), MEDLINE via Ovid (1966 to May 2009); EMBASE via Ovid (1980 to May 2009); the Oxford Pain Relief Database (1950 to 1994); and reference lists of articles.
Selection criteria: Randomised, double-blind, placebo-controlled clinical trials of oral acemetacin for relief of acute postoperative pain in adults.
Data collection and analysis: Two review authors independently assessed trial quality and extracted data. The area under the "pain relief versus time" curve was used to derive the proportion of participants with acemetacin and placebo experiencing least 50% pain relief over 4 to 6 hours, using validated equations. The number needed to treat to benefit (NNT) was calculated using 95% confidence intervals. The proportion of participants using rescue analgesia over a specified time period, and time to use of rescue analgesia, were sought as additional measures of efficacy. Information on adverse events and withdrawals was also collected.
Main results: No study fulfilled the inclusion criteria.
Authors' conclusions: In the absence of randomised evidence of efficacy for oral acemetacin in acute postoperative pain, we cannot, at present, make any conclusions regarding its effectiveness. Because trials clearly demonstrating analgesic efficacy in the most basic of acute pain studies is lacking, use in other indications should be evaluated carefully. Given the large number of available drugs of this kind and similar classes, there is no urgent research agenda for this drug.
Conflict of interest statement
SD, RAM & HJM have received research support from charities, government and industry sources at various times. RAM and HJM have consulted for various pharmaceutical companies. RAM, and HJM have received lecture fees from pharmaceutical companies related to analgesics and other healthcare interventions. Support for this review came from Oxford Pain Research, the NHS Cochrane Collaboration Programme Grant Scheme, and NIHR Biomedical Research Centre Programme.
Update of
- doi: 10.1002/14651858.CD007589
References
References to studies excluded from this review
Szabados 1986 {published data only}
-
- Szabados T. Double‐blind testing of acemetacin and phenylbutazone in pain and inflammations after episiotomy [Doppelblindprüfung von Acemetacin und Phenylbutazon bei Schmerzen und Entzündungen nach Episiotomie]. Die Medizinische Welt 1986;37:703‐6. [CENTRAL: CN‐00309541]
References to studies awaiting assessment
Kamiya 1981 {published data only}
-
- Kamiya K, et al. Clinical evaluation of K‐708 (Acemetacin) for the management of pain and inflammation due to minor surgery and trauma: A double‐blind study with Clofezone [Shoshujutsu, gaisho ni yoru totsu, ensho ni taisuru K‐708 (asemetashin) no rinsho hyoka: kurofezon to no niju moken shiken]. Yakuri to Chiryo (Japanese Pharmacology and Therapeutics) 1981;9(9):3875‐85.
Tsuyama 1981 {published data only}
-
- Tsuyama N, et al. Clinical investigation of acemetacin (K‐708) for the management of pain and inflammation due to surgical stress in the field of orthopedics [Seikei Geka Ryoiki no Shujutsu Shinshu ni Yoru Totsu, Ensho ni Taisuru Asemetashin (K‐708) no Rinshoteki Kento]. Yakuri to Chiryo (Japanese Pharmacology and Therapeutics) 1981;9(9):3843‐62.
Additional references
Barden 2004
-
- Barden J, Edwards JE, McQuay HJ, Wiffen PJ. Relative efficacy of oral analgesics after third molar extraction. British Dental Journal 2004;197(7):407‐11. - PubMed
Chavez‐Pina 2007
Chou 2002
-
- Chou CT, Tsai YY. A double‐blind, randomized, controlled parallel group study evaluating the efficacy and safety of acemetacin for the management of osteoarthritis. International Journal of Clinical Pharmacology Research 2002;22(1):1‐6. - PubMed
Clarke 2009
Collins 1997
-
- Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres?. Pain 1997;72:95‐7. - PubMed
Collins 2001
-
- Collins SL, Edwards J, Moore RA, Smith LA, McQuay HJ. Seeking a simple measure of analgesia for mega‐trials: is a single global assessment good enough?. Pain 2001;91(1‐2):189‐94. - PubMed
Cook 1995
Cooper 1991
-
- Cooper SA. Single‐dose analgesic studies: the upside and downside of assay sensitivity. The Design of Analgesic Clinical Trials. Advances in Pain Research Therapy 1991;18:117‐24.
Derry 2008
Derry C 2009a
Derry C 2009b
Derry P 2009
Fitzgerald 2001
-
- FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase‐2. New England Journal of Medicine 2001;345(6):433‐42. - PubMed
Hawkey 1999
-
- Hawkey CJ. Cox‐2 inhibitors. Lancet 1999;353(9149):307‐14. - PubMed
Jadad 1996a
-
- Jadad AR, Carroll D, Moore RA, McQuay H. Developing a database of published reports of randomised clinical trials in pain research. Pain 1996;66(2‐3):239‐46. - PubMed
Jadad 1996b
-
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
L'Abbe 1987
-
- L'Abbé KA, Detsky AS, O'Rourke K. Meta‐analysis in clinical research. Annals of Internal Medicine 1987;107:224‐33. - PubMed
Leeb 2004
-
- Leeb BF, Bucsi L, Keszthelyi B, Bohmova J, Valesova M, Hawel R, et al. Treatment of osteoarthritis of the knee joint. Efficacy and tolerance to acemetacin slow release in comparison to celecoxib [Behandlung der Gonarthrose. Wirksamkeit und Verträglichkeit von retardiertem Acemetacin im Vergleich zu Celecoxib]. Der Orthopade 2004;33(9):1032‐41. [CENTRAL: CN‐00489616; PUBMED: PUBMED 15156311] - PubMed
Lloyd 2009
McQuay 2005
Moore 1996
Moore 1997a
Moore 1997b
Moore 1997c
Moore 1998
Moore 2003
-
- Moore RA, Edwards J, Barden J, McQuay HJ. Bandolier's Little Book of Pain. Oxford: Oxford University Press, 2003. [ISBN: 0‐19‐263247‐7]
Moore 2005
Moore 2006
-
- Moore A, McQuay H. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press, 2006. [ISBN: 0‐19‐856604‐2]
Moore 2008
Morris 1995
Müller 1986a
-
- Müller P, Dammann HG, Simon B. Stomach tolerance of indomethacin derivatives: an endoscopic comparative study in healthy probands [Magenverträglichkeit von Indometacin und Indometacin‐Derivaten: eine endoskopische Vergleichsstudie an gesunden Probanden]. Zeitschrift fur Rheumatologie 1986;45(2):68‐70. [CENTRAL: CN‐00043593; PUBMED: PUBMED 3524065] - PubMed
Müller 1986b
-
- Müller P, Dammann HG, Simon B. Gastroduodenal tolerability of indomethacin and acetaminophen. A comparative endoscopic study in healthy subjects [Gastroduodenale Verträglichkeit von Indometacin und Acemetacin. Eine endoskopische Vergleichsstudie bei gesunden Probanden]. Arzneimittelforschung 1986;36(2):269‐70. [CENTRAL: CN‐00042373; PUBMED: PUBMED 3964334] - PubMed
Müller 1989
-
- Müller P, Dammann HG, Langer M, Leucht U, Simon B. Ranitidine ameliorates acemetacin and indomethacin‐induced changes of the gastroduodenal mucosa, without modifying the pharmacokinetic behavior of both antirheumatic drugs [Ranitidin vermindert die durch Acemetacin und Indometacin induzierten gastroduodenalen Schleimhautveränderungen, ohne das pharmakokinetische Verhalten beider Antirheumatika zu beeinflussen]. Zeitschrift fur Gastroenterologie 1989;27(2):83‐6. [CENTRAL: CN‐00060312; PUBMED: PUBMED 2658392] - PubMed
PACT 2007
-
- Prescription Cost Analysis. England 2007. [ISBN: 978‐1‐84636‐210‐1]
Roy 2007
Saul 1991
-
- Saul PA, Korlipara K. Acemetacin and indomethacin in the treatment of rheumatoid arthritis: a double‐blind comparative study in general practice. Current Medical Research and Opinion 1991;12(5):332‐41. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
